2X BLEND CJC-1295 WITHOUT DAC (5MG) / IPAMORELING (5MG)

Description

2X Blend CJC-1295 Without DAC (5mg) / Ipamorelin (5mg) is a research material supplied for controlled laboratory environments and analytical peptide characterization studies. This product is intended exclusively for non-clinical research applications involving peptide analysis, method development, and investigational laboratory workflows conducted within qualified research facilities.

This dual-peptide formulation combines CJC-1295 without DAC and Ipamorelin in a single research vial to support experimental investigations focused on growth hormone–related signaling pathways, peptide stability, and analytical interaction profiling. The absence of DAC (Drug Affinity Complex) in the CJC-1295 component allows researchers to study short-acting peptide kinetics and comparative signaling behavior under controlled laboratory conditions.

Composition

• CJC-1295 (Without DAC)
• Ipamorelin
• Appearance: Lyophilized powder in a sealed research vial

Research Focus (Non-Clinical)

• Analytical identification and purity verification using HPLC and LC-MS methodologies
• Comparative peptide stability analysis under laboratory-controlled conditions
• Assay development for growth hormone–related receptor signaling studies
• Method development for peptide interaction profiling and quantitative analysis
• Chromatographic optimization for impurity detection and batch consistency evaluation

Researchers may utilize this blend in laboratory workflows designed to examine peptide structure, degradation patterns, molecular interactions, and signaling response modeling. Studies often involve controlled reconstitution, analytical measurement, and documentation processes to ensure reproducibility and data integrity within non-clinical research environments.

For Qualified Research Use Only

This research material is supplied solely for use by qualified professionals operating within institutional, academic, or private laboratory settings. It is not intended for human or veterinary use and must not be used for diagnostic, therapeutic, or clinical purposes. Investigators are responsible for ensuring that all research activities involving this material comply with applicable institutional guidelines, laboratory safety standards, and regulatory frameworks governing non-clinical research materials.

Documentation and Quality Assurance

Each lot of 2X Blend CJC-1295 Without DAC / Ipamorelin is sourced through a verified global supply chain with an emphasis on traceability, documentation integrity, and quality oversight. Our quality process includes internal review of available Certificates of Analysis and third-party analytical reports, such as HPLC and LC-MS data, as they become available.

Independent third-party testing is performed on select lots to confirm peptide identity, purity, and alignment with internal specifications. Analytical documentation is reviewed for consistency and accuracy prior to release. Where applicable, reported test methods and results may be referenced by research teams as part of their internal validation and documentation processes.

Important Notice

This product is intended for laboratory research use only. It is not a drug, medical device, or dietary supplement and has not been evaluated by the U.S. Food and Drug Administration. This material must not be used for human consumption, veterinary application, diagnosis, treatment, or prevention of any disease or condition.

Use of this research material outside of controlled laboratory environments or by unqualified individuals is strictly prohibited.

Quality and Manufacturing Standards

All research materials are sourced from carefully vetted domestic and international manufacturing partners that operate under quality systems consistent with ISO and cGMP principles. Supplier qualification includes evaluation of production controls, analytical documentation practices, and transparency in testing methodologies.

We require a verified purity threshold of 99% or higher for peptide materials and conduct independent third-party spot testing to confirm that select lots meet internal standards for identity, purity, and composition. Where available, endotoxin testing results may be included on Certificates of Analysis for laboratory quality assessment purposes only and do not imply suitability for clinical or veterinary use.

All materials are sealed for integrity and packaged to maintain stability throughout manufacturing, handling, and final delivery to research facilities.

Laboratory Research Standards and Intended Use

Research teams implementing this material often follow standardized receiving and verification procedures to support consistency across experimental workflows. Common laboratory practices may include inspection of container integrity, confirmation of labeling against internal records, reconciliation of available analytical documentation, and maintenance of detailed chain-of-custody logs.

Investigators may reference provided analytical reports as part of internal quality workflows while conducting independent confirmation steps appropriate to their specific study design. Maintaining clear documentation supports data integrity, reproducibility, and alignment with institutional research protocols.

All experimental work involving this material should be conducted by trained personnel using appropriate controls, validated methodologies, and documented oversight within approved laboratory environments.